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Amniocentesis for genetic diagnosis began in the late
1960s and early 1970s as a tertiary procedure reserved
for only the highest-risk patients.1,2 Although this pro-
cedure is familiar in clinical practice, the role of am-
niocentesis continues to focus mainly on the detection
of chromosomal abnormalities and well-known clini-
cally evident or hereditary genetic diagnoses.3 It is
often applied in older women (age ≥34 years old) and
high risk younger women (less than 1/270) who have
undergone maternal blood Down syndrome screen-
ing. The main target for evaluation in amniocentesis
is cells derived from amniotic fluid. However, the resid-
ual amniotic fluid without cells is often disregarded.
It would be welcome if the contents of the amniotic
fluid could provide further information regarding
pregnancy outcome.
In this issue of the Journal of the Chinese Medical
Association, a team of investigators from Taichung
Veterans General Hospital pioneered a study of the
chemokine, stromal cell-derived factor-1α (SDF-1α;
also known as chemokine ligand12 [CXCL12]) of the
amniotic fluid, and evaluated the clinical significance
of SDF-1α in pregnant women.4 They studied amni-
otic fluid obtained from mid-trimester women and
found that the use of a cut-off value of SDF-1α of
6.42 pg/mL could provide optimal sensitivity and
specificity in predicting pregnancy outcomes such as
Apgar score at 1 minute, preterm birth rate, fetal birth
weight and the possibility of being small for gestational
age. This study offers a vision of reusing the “wasted
amniotic fluid”. In addition, the authors provide use-
ful information to show that the concentration of
SDF-1α in amniotic fluid might be a prognostic fac-
tor in the future. However, is this reality or only a
myth? This issue requires our attention.
SDF-1α, a member of the superfamily of chemoat-
tractant cytokines known as chemokines, regulates
many essential biological processes, including cardiac
and neuronal development, stem cell motility, neo-
vascularization, angiogenesis, apoptosis, and tumori-
genesis.5 In mice genetically deleted of SDF-1α,6
early-stage embryos exhibit profound defects in the
formation of large vessels, as well as other morpho-
logical anomalies such as septal malformation during
cardiac development and abnormal brain patterning,
including a disorganized cerebellum. Ultimately, em-
bryonic lethality is observed typically between days
15 and 18 of gestation, suggesting the critical role of
SDF-1α in successful pregnancy outcome. Recently,
Zhou et al7 investigated the role of SDF-1α and its
receptor CXCR4 in the interaction of trophoblasts
and decidual stromal cells and found that CXCR4 was
present in both human trophoblasts and decidual stro-
mal cells, but only human trophoblasts secreted SDF-
1α spontaneously in vitro. In addition, SDF-1α
induced an apparent increase in the invasiveness of tro-
phoblasts, and upregulated matrix metalloproteinase
(MMP) 9 and MMP2 activity of both trophoblasts
and decidual stromal cells in an autocrine and paracrine
manner. The invasiveness and MMP9 and MMP2 ac-
tivity of trophoblasts in co-culture with decidual stro-
mal cells increased significantly, and these could be
inhibited by anti-CXCR4 neutralizing antibody. These
results suggest that SDF-1α secreted by human tro-
phoblasts enhances the coordination between tro-
phoblasts and decidual stromal cells via the regulation
of MMP9 and MMP2, which may improve the func-
tional maternofetal interface. However, Tseng et al’s
data4 showed a relatively confusing result, since they
found that higher concentration of SDF-1α in the
amniotic fluid (≥ 6.42 pg/mL) might be correlated
with low Apgar score at 1 minute, higher preterm birth
rate, lower fetal birth weight and possibility of being
small for gestational age. In addition, concentration
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of SDF-1α in the amniotic fluid was not correlated
with other possible placental diseases, such as pre-
eclampsia.8 That seems to be different from Zhou 
et al’s report, which showed that increased SDF-1α
may improve the functional maternofetal interface.7
The possible reasons include: (1) differential timing
of SDF-1α secretions in utero; (2) SDF-1α functions
in both autocrine and paracrine manners; and (3)
concentration of SDF-1α in the amniotic fluid does
not necessarily correlate with the biologic activity in
target tissues. Of course, the other possible reason is
only an incidental finding or a minor role of SDF-1α
in Tseng et al’s report, and testing concentration of
SDF-1α in the amniotic fluid can be disregarded,
because many articles testing the relationship between
amniotic fluid levels of cytokines and future pregnancy
outcome are finally not reproducible. For example,
the hypothesis that amniotic fluid levels of annexin
A5 (AF-AnxA5) may be associated with intrauterine
growth restriction9 was tested with failure to get the
same conclusion.10
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